-
公开(公告)号:US20220257619A1
公开(公告)日:2022-08-18
申请号:US17627000
申请日:2020-07-17
发明人: Susan Autio , Keith Edward Branham , James A. Filice , John W. Gibson , John J. Leonard , James Matriano , Whitney Moro , Michael Sekar , Chelsea Alexandra Snyder , Robert G. Strickley , Raju Subramanian , Felix Theeuwes , Monica Tijerina , Jeremy C. Wright , Su Il Yum , Faye Xu
IPC分类号: A61K31/675 , A61K47/26 , A61K47/34 , A61K47/22 , A61P31/18
摘要: The present disclosure provides long-acting formulations of tenofovir alafenamide, methods of making the same and methods of using the same.
-
公开(公告)号:US20190209654A1
公开(公告)日:2019-07-11
申请号:US16179704
申请日:2018-11-02
申请人: Durect Corporation
发明人: William Van Osdol , SuIl Yum , Felix Theeuwes , Michael Sekar , John W Gibson , Keith Edward Branham , Huey Ching Su
IPC分类号: A61K38/21 , A61K47/64 , A61K47/52 , A61K47/54 , A61K38/27 , A61K9/00 , A61K31/7052 , A61K47/34 , A61K47/26 , A61K47/14 , A61K38/26
CPC分类号: A61K38/212 , A61K9/0019 , A61K31/7052 , A61K38/26 , A61K38/27 , A61K47/14 , A61K47/26 , A61K47/34 , A61K47/52 , A61K47/541 , A61K47/64
摘要: The present disclosure provides a biodegradable drug delivery composition including a vehicle and an insoluble component comprising beneficial agent dispersed in the vehicle. Typically, the composition is not an emulsion, but has a low viscosity and further provides for minimized initial burst and sustained release of the beneficial agent over time. Also provided, are kits including the biodegradable drug delivery composition or components thereof, as well as methods of making and using the biodegradable drug delivery composition.
-
公开(公告)号:US11529420B2
公开(公告)日:2022-12-20
申请号:US16935110
申请日:2020-07-21
申请人: Durect Corporation
发明人: Michael Sekar , Felix Theeuwes , Keith Edward Branham , John W Gibson , James Matriano , Whitney Moro , John Tipton , William Van Osdol , Su Il Yum
IPC分类号: A61K31/352 , A61K31/706 , A61K31/785 , A61K38/26 , A61K38/27 , A61K47/54 , A61K9/16 , A61K9/19 , A61K9/00 , A61K47/59 , A61K38/28 , A61K38/31 , A61K39/395
摘要: The present disclosure generally provides complexes including a pharmaceutically active agent and a functionalized polymer, wherein the functionalized polymer includes repeat units, the repeat units including ionizable repeat units having at least one ionizable side group and/or ionizable end group, a plurality of the at least one ionizable groups forming non-covalent bonds with the pharmaceutically active agent. Polymers which may be used to form such complexes as well as methods of making and using the complexes and related compositions are also provided.
-
公开(公告)号:US20210322517A1
公开(公告)日:2021-10-21
申请号:US17222703
申请日:2021-04-05
申请人: DURECT CORPORATION
发明人: William Van Osdol , Su Il Yum , Felix Theeuwes , Michael Sekar , John W Gibson , Keith Edward Branham , Huey-Ching L. Su
IPC分类号: A61K38/21 , A61K47/54 , A61K47/52 , A61K47/64 , A61K47/14 , A61K47/26 , A61K47/34 , A61K9/00 , A61K31/7052 , A61K38/26 , A61K38/27
摘要: The present disclosure provides a biodegradable drug delivery composition including a vehicle and an insoluble component comprising beneficial agent dispersed in the vehicle. In some cases, the composition includes sucrose acetate isobutyrate, biodegradable polymer, hydrophobic solvent, and a complex comprising a counterion and beneficial agent, such as protein, peptide, nucleic acid, or small molecular weight compound. Also provided, are kits including the biodegradable drug delivery composition or components thereof, as well as methods of making and using the biodegradable drug delivery composition.
-
公开(公告)号:US20210038731A1
公开(公告)日:2021-02-11
申请号:US16935110
申请日:2020-07-21
申请人: Durect Corporation
发明人: Michael Sekar , Felix Theeuwes , Keith Edward Branham , John W. Gibson , James Matriano , Whitney Moro , John Tipton , William Van Osdol , Su Il Yum
IPC分类号: A61K47/54 , A61K9/16 , A61K9/19 , A61K9/00 , A61K47/59 , A61K38/26 , A61K31/352 , A61K31/706 , A61K31/785 , A61K38/27 , A61K38/28 , A61K38/31 , A61K39/395
摘要: The present disclosure generally provides complexes including a pharmaceutically active agent and a functionalized polymer, wherein the functionalized polymer includes repeat units, the repeat units including ionizable repeat units having at least one ionizable side group and/or ionizable end group, a plurality of the at least one ionizable groups forming non-covalent bonds with the pharmaceutically active agent. Polymers which may be used to form such complexes as well as methods of making and using the complexes and related compositions are also provided.
-
-
-
-